IMBiologics
₩12,600
0
-₩470-3.6% 06:30 Today
Statistics
Day High
12,970
Day Low
12,400
52W High
104,000
52W Low
12,400
Volume
48,908
Avg. Volume
117,151
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
IMBiologics Corp., a biotechnology company, engages in developing immunomodulatory antibody therapeutics to treat autoimmune diseases and cancer. The company uses Optimal Antibody Modality Manufacturing Technology (IM-OpDECon) for developing differentiated treatments for autoimmune diseases and immuno-oncology based on immuno-modulatory biologics. Its products include IMB-101, a bispecific therapeutic antibody that targets OX40L and TNF to modulate pathological immune mechanisms mediating Th1/Th17 immune responses; IMB-102; IMB-201, an antibody-drug conjugate that targets HLA-G, a tumor-specific antigen; IMB-402, a concept anticancer vaccine bispecific antibody that utilizes the ePENDY (IgM-Agonist) modality to activate cancer cell-specific T cells. IMBiologics Corp. was founded in 2020 and is based in Suwon-si, South Korea.
Show More
CEO
Mr. Gyongsik Ha Ph.D.
Country
South Korea
ISIN
KR7493280002
Listings
0 Comments
Share your thoughts
FAQs
What is IMBiologics stock price today?▼
The current price of 493280.KQ is ₩12,600 KRW — it has decreased by -3.6% in the past 24 hours. Watch IMBiologics stock price performance more closely on the chart.
What is IMBiologics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange IMBiologics stocks are traded under the ticker 493280.KQ.
In which sector is IMBiologics located?▼
IMBiologics operates in the Other sector.
When did IMBiologics complete a stock split?▼
IMBiologics has not had any recent stock splits.
Where is IMBiologics headquartered?▼
IMBiologics is headquartered in Suwon-si, South Korea.